Histamine H3 Receptor Antagonists for Alzheimer's Disease: A Systematic Review and Meta-Analysis of Randomized Placebo-Controlled Trials

Momoko Kubo, Taro Kishi, Shinji Matsunaga, Nakao Iwata

Research output: Contribution to journalReview article

10 Citations (Scopus)

Abstract

Background: No comprehensive meta-analysis has been performed concerning the efficacy and tolerability of histamine H3 receptor antagonists (H3R-ANTs) in Alzheimer's disease patients. Objective: We performed a systematic review and meta-analysis of double-blind randomized placebo-controlled trials (RCTs) of H3R-ANTs for Alzheimer's disease. Methods: Relevant studies were identified through searches of PubMed ®, databases of the Cochrane Library

Original languageEnglish
Pages (from-to)667-671
Number of pages5
JournalJournal of Alzheimer's Disease
Volume48
Issue number3
DOIs
Publication statusPublished - 01-10-2015

Fingerprint

Histamine H3 Antagonists
Meta-Analysis
Alzheimer Disease
Randomized Controlled Trials
Placebos
Histamine H3 Receptors
PubMed
Libraries
Databases

All Science Journal Classification (ASJC) codes

  • Clinical Psychology
  • Geriatrics and Gerontology
  • Psychiatry and Mental health

Cite this

@article{25bbd392a5f64cc0a50911b0f0e2341b,
title = "Histamine H3 Receptor Antagonists for Alzheimer's Disease: A Systematic Review and Meta-Analysis of Randomized Placebo-Controlled Trials",
abstract = "Background: No comprehensive meta-analysis has been performed concerning the efficacy and tolerability of histamine H3 receptor antagonists (H3R-ANTs) in Alzheimer's disease patients. Objective: We performed a systematic review and meta-analysis of double-blind randomized placebo-controlled trials (RCTs) of H3R-ANTs for Alzheimer's disease. Methods: Relevant studies were identified through searches of PubMed {\circledR}, databases of the Cochrane Library",
author = "Momoko Kubo and Taro Kishi and Shinji Matsunaga and Nakao Iwata",
year = "2015",
month = "10",
day = "1",
doi = "10.3233/JAD-150393",
language = "English",
volume = "48",
pages = "667--671",
journal = "Journal of Alzheimer's Disease",
issn = "1387-2877",
publisher = "IOS Press",
number = "3",

}

Histamine H3 Receptor Antagonists for Alzheimer's Disease : A Systematic Review and Meta-Analysis of Randomized Placebo-Controlled Trials. / Kubo, Momoko; Kishi, Taro; Matsunaga, Shinji; Iwata, Nakao.

In: Journal of Alzheimer's Disease, Vol. 48, No. 3, 01.10.2015, p. 667-671.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Histamine H3 Receptor Antagonists for Alzheimer's Disease

T2 - A Systematic Review and Meta-Analysis of Randomized Placebo-Controlled Trials

AU - Kubo, Momoko

AU - Kishi, Taro

AU - Matsunaga, Shinji

AU - Iwata, Nakao

PY - 2015/10/1

Y1 - 2015/10/1

N2 - Background: No comprehensive meta-analysis has been performed concerning the efficacy and tolerability of histamine H3 receptor antagonists (H3R-ANTs) in Alzheimer's disease patients. Objective: We performed a systematic review and meta-analysis of double-blind randomized placebo-controlled trials (RCTs) of H3R-ANTs for Alzheimer's disease. Methods: Relevant studies were identified through searches of PubMed ®, databases of the Cochrane Library

AB - Background: No comprehensive meta-analysis has been performed concerning the efficacy and tolerability of histamine H3 receptor antagonists (H3R-ANTs) in Alzheimer's disease patients. Objective: We performed a systematic review and meta-analysis of double-blind randomized placebo-controlled trials (RCTs) of H3R-ANTs for Alzheimer's disease. Methods: Relevant studies were identified through searches of PubMed ®, databases of the Cochrane Library

UR - http://www.scopus.com/inward/record.url?scp=84943802641&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84943802641&partnerID=8YFLogxK

U2 - 10.3233/JAD-150393

DO - 10.3233/JAD-150393

M3 - Review article

C2 - 26402104

AN - SCOPUS:84943802641

VL - 48

SP - 667

EP - 671

JO - Journal of Alzheimer's Disease

JF - Journal of Alzheimer's Disease

SN - 1387-2877

IS - 3

ER -